How to control the economic burden of treating cardio-cerebrovascular diseases in China? Assessment based on System of Health Accounts 2011

Abstract

How to control the economic burden of treating cardio-cerebrovascular diseases in China? Assessment based on System of Health Accounts 2011 Background In the past two decades, chronic non-communicable diseases have become the leading disease burden, and cardio-cerebrovascular diseases (CCVD) are the main causes of death in chronic diseases. It has become the focus of global public health attention, in this study, System of Health Accounts 2011 (SHA 2011) is used to calculate health expenditure, discuss its economic burden, and put forward countermeasures. Methods Data were collected by multi-stage stratified random sampling and the medical expenses of patients with CCVD were calculated based on SHA 2011, from the dimensions of the financing plan, institutional flow, and service function. Correlation and regression analysis were conducted by controlling factors influencing hospitalization expenses. All analysis were conducted by software SPSS. Results The current health expenditure (CHE) of CCVD in Dalian was 3.986 billion Yuan, accounting for 12.88% of the CHE (30.947 billion Yuan). The current curative expenditure (CCE) of CCVD was 2.947 billion Yuan. 40.39% of CCVD financing came from social medical insurance, and the proportion of family health financing was higher (39.06%). The expenditures were consumed by general hospitals and elderly patients. Conclusions The expenditure burden of CCVD in Dalian was massive, and wasted the health resource severely. It is necessary for the government to adjust the financing structure, reallocate the expenses of CCVD, and make institutional flow and functional distribution more reasonable. Electronic supplementary material: The online version of this article contains supplementary material.

Research on Current Curative Expenditure and Influencing Factors Among Cardiovascular and Cerebrovascular Diseases Based on “System of Health Accounts 2011”

“…The rapid growth of inpatient services is the main driving force of the growth of medical expenses [15]. According to the regression analysis of the influencing factors of hospitalization expenses, the length of stay is the most important factor, which is consistent with other research results [16]. Logically, the longer the length of hospital stay, the more medical resources will be consumed, which leads to higher hospital costs [17].…”

Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis

“…Chronic diseases have become a global economic burden [27]. Our study revealed that the prevalence of chronic underlying diseases in dead patients with COVID-19 was 72.21% (95% CI 62.85-79.96%).…”

Current curative expenditure of non-communicable diseases changed in Dalian, China from 2017 to 2019: a study based on ‘System of Health Accounts 2011’

“…Then, the ratio is multiplied by the total medical expenses to obtain the total medical expenses of patients with NCDs in Dalian. The specific accounting methods and steps can refer to the previous articles published by our team, and NCDs replaced only the corresponding ICD-10 code 34. All expenditures were converted from reported currencies to 2019 China Yuan.…”